63 filings
Page 2 of 4
6-K
etchmbb58ot6me4bv
8 Jun 23
Current report (foreign)
4:30pm
6-K
w7hpauymt bdgjgp
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
bkljmz6hfl6of5
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
m1hsszk1neenzdyt
15 May 23
Condensed Financial Statements
4:51pm
6-K/A
1b10q4b4
4 May 23
Annual General Meeting of Shareholders to Be
8:19am
6-K
sgaf6k0n63
3 May 23
Annual General Meeting of Shareholders to Be
5:25pm
6-K
d6avnuf7 gp1wfw6
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
i4t k7ydoxgm
28 Mar 23
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery
9:16am
6-K
r44roln
16 Mar 23
Current report (foreign)
8:09am
6-K
d5m377474qn6fw6l
14 Mar 23
PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery
8:05am
6-K
tpi5hkkrr82 4v
7 Feb 23
Current report (foreign)
4:11pm
6-K
25d0ow jtu
29 Dec 22
Current report (foreign)
4:31pm
6-K
3ktp0qz4y 8sl
25 Nov 22
Annual General Meeting of Shareholders to Be
4:30pm
6-K
fxw3gkd vwe5xjaevh
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
46c 7jbv9zpn55um68
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
yj37lt
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am
6-K
wu3jf
4 Oct 22
PainReform Provides PRF-110 Manufacturing Update
10:21am
6-K
49a45e56gwzqrwd
16 Aug 22
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
8:08am
6-K
62iirq6086pxiq
15 Aug 22
Current report (foreign)
6:16pm
6-K
n2b1r
29 Jul 22
Investor Presentation July 2022
4:30pm